oxazolidin-2-one has been researched along with Bacterial Pneumonia in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 31 (55.36) | 29.6817 |
2010's | 23 (41.07) | 24.3611 |
2020's | 2 (3.57) | 2.80 |
Authors | Studies |
---|---|
De Anda, C; Fujimi, S; Kusachi, S; Mikamo, H; Nagashima, M; Oshima, N; Takase, A | 1 |
Roch, M; Rosato, AE; Taglialegna, A; Varela, MC | 1 |
Chopin, MC; Faure, K; Flateau, C; Guery, B; Harent, S; Vuotto, F; Wallet, F | 1 |
Chambers, RB; Deminski, MC; Haider, S; Louder, AM; Pasquale, MK | 1 |
Caffrey, AR; Laplante, KL; Morrill, HJ; Puzniak, LA | 1 |
Awad, SS; Chuang, YC; Engelhardt, M; Marjanek, Z; Pareigis, AJ; Reis, G; Rodriguez, AH; Sánchez, AS; Saulay, M; Scheeren, TW; Zhou, X | 1 |
Ballinger, MN; Bhan, U; Keshamouni, V; Kovach, MA; Podsiad, AB; Standiford, TJ | 1 |
Kaysin, A; Viera, AJ | 1 |
Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF | 1 |
Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X | 1 |
Barman, TK; Bhadauriya, T; Bhateja, P; Bhatnagar, PK; Das, B; Khan, S; Malhotra, S; Mathur, T; Paliwal, J; Pandya, M; Rao, M; Singhal, S; Sood, R; Upadhyay, DJ | 1 |
Lam, AP; Wunderink, RG | 2 |
Marco, JA; Naranjo, OR; Rodríguez de Castro, F; Violán, JS | 1 |
Batjom, E; Borne, M; Brinquin, L; Cirodde, A; Janvier, F; Libert, N; Nizou, JY | 1 |
Alvarez, F; Cereijo, E; Latorre, MM; Martínez, H; Oltra, R; Rodríguez, O | 1 |
Biancofiore, G; Dal Canto, L; Didoni, G; Doria, R; Filipponi, F; Furneri, G; Gemignani, G; Malacarne, P; Menichetti, F; Mosca, C; Papineschi, F; Passaglia, C; Procaccini, M; Tascini, C; Urbani, L | 1 |
Rubinstein, E; Vinh, DC | 1 |
Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C | 1 |
Stein, GE; Wells, EM | 1 |
Hermsen, ED; Kalil, AC; Murthy, MH; Neto, FK; Rupp, ME; Sun, J | 1 |
Eden, A; Le Falher, G; Le Moing, V; Lesnik, A; Makinson, A; Reynes, J | 1 |
Burkhardt, O; Pletz, MW; Welte, T | 1 |
Cauda, R; Esposito, S; Garau, J; Gould, IM; Gudiol, F; Mazzei, T | 1 |
Huang, DB; Ijzerman, MM; Tack, KJ | 1 |
Acquarolo, A; Carori, G; Fiorese, B; Magri, S; Pantosti, A; Signorini, L; Soavi, L; Stellini, R; Suter, F | 1 |
Gould, FK | 1 |
Aleyrangues, L; Chiron, R; Counil, F; Dumitrescu, O; Filleron, A; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Reverdy, ME | 1 |
Lemonovich, TL; Watkins, RR | 1 |
Avazashvili, N; Chikviladze, D; Gachechiladze, Kh; Metreveli, D; Mikeladze, M; Nozadze, T | 1 |
Blennow, O; Fröding, I; Ozenci, V; Westling, K | 1 |
Amsler, K; Arbit, D; Balis, D; File, TM; Kaul, P; Michiels, B; Nicholson, SC; Noel, GJ; Strauss, RS; Welte, T | 1 |
Clark, CR; Karau, MJ; Patel, R; Rajagopalan, G; Schmidt, SM; Tilahun, AY | 1 |
Arnold, FW; Griffin, AT; Peyrani, P; Ramirez, JA; Wiemken, TL | 1 |
Wunderink, RG | 1 |
Pigrau, C | 1 |
Cammarata, SK; Kollef, MH; Oliphant, TH; Wunderink, RG | 1 |
Adler, S; Bruss, JB; Deville, J; Edge-Padbury, B; Jantausch, BA; Lopez, P; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
Cammarata, SK; Kuter, DJ; Le, VH; Nasraway, SA; O'Grady, N; Shorr, AF | 1 |
Cepeda, JA; Cooper, B; Hails, J; Hayman, S; Jones, K; Kibbler, C; Kwaku, F; Shaw, S; Shulman, R; Singer, M; Taylor, L; Whitehouse, T; Wilson, AP | 1 |
Cammarata, SK; Croos-Dabrera, RV; Kollef, MH; Rello, J; Wunderink, RG | 1 |
Bodmann, KF | 1 |
Rollins, G | 1 |
Kalil, AC; Puumala, SE; Stoner, J | 1 |
Alvarez-Lerma, F; del Castillo, A; Grau, S; Neipp, R; Rubio-Terrés, C | 1 |
Allaouchiche, B; Boselli, E; Breilh, D; Chassard, D; Djabarouti, S; Rimmelé, T; Saux, MC; Toutain, J | 1 |
Wilcox, MH | 1 |
Hui, M | 1 |
Caillon, J; Christophe Roze, J; Denizot, S; Godon, N; Gras-Le Guen, C; Podevin, G; Potel, G | 1 |
Kollef, MH; Micek, ST; Skrupky, LP | 1 |
Plouffe, JF | 1 |
Fung, HB; Kirschenbaum, HL; Ojofeitimi, BO | 1 |
Anderson, DC; Azimi, PH; Blumer, JL; Bradley, JS; Edwards, KM; Kaplan, SL; Lobeck, FG; Patterson, L; Tan, TQ | 1 |
Hedström, SA | 1 |
Chuchalin, AG; Fesenko, OV; Fomina, IG; Grudinina, SA; Krotova, LA; Kurdiukova, IuP; Kutsenko, MA; Marinin, VF; Sidorenko, SV; Sinpal'nikov, AI; Solomatin, AS; Sterkhova, GV; Zubkov, MM | 1 |
20 review(s) available for oxazolidin-2-one and Bacterial Pneumonia
Article | Year |
---|---|
Health care-associated pneumonia: identification and initial management in the ED.
Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline | 2008 |
The role of MRSA in healthcare-associated pneumonia.
Topics: Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Risk Factors; Staphylococcal Infections; Virulence | 2009 |
New antimicrobial molecules and new antibiotic strategies.
Topics: Acetamides; Anti-Infective Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Humans; Ketolides; Linezolid; Lipopeptides; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic | 2009 |
Linezolid: a review of safety and tolerability.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Interactions; Drug Tolerance; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Monoamine Oxidase Inhibitors; Oxazolidinones; Pneumonia, Bacterial; Selective Serotonin Reuptake Inhibitors | 2009 |
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2010 |
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Education, Medical, Continuing; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Randomized Controlled Trials as Topic; Renal Insufficiency; Teicoplanin; Thrombocytopenia; Vancomycin | 2010 |
Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2010 |
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Teicoplanin; Tigecycline; Treatment Outcome; Vancomycin | 2011 |
Combined retrospective analysis of seven phase II and III trials of the efficacy of linezolid in the treatment of pneumonia caused by multidrug-resistant Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Oxazolidinones; Pneumococcal Infections; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2010 |
Linezolid: safety and efficacy in special populations.
Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Osteoarthritis; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; United Kingdom | 2011 |
How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections | 2013 |
[Oxazolidinones and glycopeptides].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Biotransformation; Cell Wall; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Histamine Release; Humans; Linezolid; Molecular Structure; Oxazolidinones; Peptidoglycan; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Vancomycin | 2003 |
[Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Infectious; Soft Tissue Infections | 2004 |
Update on linezolid: the first oxazolidinone antibiotic.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Teicoplanin; Vancomycin | 2005 |
Methicillin-Resistant S. aureus Ventilator-Associated Pneumonia: Strategies to Prevent and Treat.
Topics: Acetamides; Anti-Infective Agents; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance; Ventilators, Mechanical | 2006 |
Optimizing therapy for MRSA pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcus aureus; Tigecycline; Vancomycin | 2007 |
Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2000 |
Linezolid: an oxazolidinone antimicrobial agent.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Drug Interactions; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Soft Tissue Infections; Vancomycin Resistance | 2001 |
[Linezolide--an antibiotic with new action mechanism].
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Controlled Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 2002 |
10 trial(s) available for oxazolidin-2-one and Bacterial Pneumonia
Article | Year |
---|---|
Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing ted
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Double-Blind Method; Hospitals; Humans; Japan; Linezolid; Organophosphates; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Skin Diseases, Bacterial; Tetrazoles; Ventilators, Mechanical | 2022 |
A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia.
Topics: Acetamides; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Therapy; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Young Adult | 2014 |
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2008 |
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Disease Eradication; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Young Adult | 2012 |
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2003 |
Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Thrombocytopenia; Vancomycin | 2003 |
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Critical Care; Critical Illness; Cross Infection; Double-Blind Method; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Pneumonia, Bacterial; Respiratory Tract Infections; Sepsis; Soft Tissue Infections; Teicoplanin; Treatment Outcome | 2004 |
Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group.
Topics: Acetamides; Adolescent; Anti-Infective Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Microbial; Female; Hospitalization; Humans; Infant; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Time Factors | 2001 |
[Comparison of linezolid and vancomycin in nosocomial pneumonia: results of the multicenter double-blind study].
Topics: Acetamides; Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Cross Infection; Double-Blind Method; Drug Resistance, Bacterial; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial | 2002 |
26 other study(ies) available for oxazolidin-2-one and Bacterial Pneumonia
Article | Year |
---|---|
Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients.
Topics: Adult; Animals; Anti-Bacterial Agents; Child; Coinfection; Cystic Fibrosis; Humans; Larva; Mice; Microbial Sensitivity Tests; Moths; Oxazolidinones; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Sputum; Staphylococcal Infections; Staphylococcus aureus; Tetrazoles; Whole Genome Sequencing | 2020 |
[Nocardia pseudobrasiliensis pneumonia in a heart transplant recipient].
Topics: Acetamides; Adult; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Heart Transplantation; Humans; Imipenem; Immunocompromised Host; Linezolid; Male; Nocardia; Nocardia Infections; Oxazolidinones; Pneumonia, Bacterial; Postoperative Complications; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Out-of-pocket costs and prescription reversals with oral linezolid.
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Databases, Factual; Drug Substitution; Financing, Personal; Health Maintenance Organizations; Humans; Linear Models; Linezolid; Medicare Part D; Middle Aged; Oxazolidinones; Patient Readmission; Pneumonia, Bacterial; Retrospective Studies; Soft Tissue Infections; United States; Young Adult | 2013 |
Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Databases, Factual; Electronic Health Records; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Propensity Score; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Vancomycin; Veterans | 2014 |
Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia.
Topics: Acetamides; Animals; Humans; Immunomodulation; Influenza A Virus, H1N1 Subtype; Influenza, Human; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections | 2015 |
Community-Acquired Pneumonia in Adults: Diagnosis and Management.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Doxycycline; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Macrolides; Male; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2016 |
Novel biaryl oxazolidinones: in vitro and in vivo activities with pharmacokinetics in an animal model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Mice; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia, Bacterial; Sepsis; Survival Analysis | 2009 |
[Successful treatment of life-threatening Panton-Valentine leucocidin positive Staphylococcus aureus pneumonia with antibiotics and immunoglobulins targeting the toxin production].
Topics: Acetamides; Adult; Anti-Infective Agents; Bacterial Toxins; Clindamycin; Exotoxins; Humans; Immunoglobulins, Intravenous; Leukocidins; Linezolid; Male; Multiple Organ Failure; Oxazolidinones; Pneumonia, Bacterial; Respiratory Distress Syndrome; Staphylococcal Infections | 2009 |
Use of linezolid in critically ill patients admitted to intensive care units.
Topics: Acetamides; Anti-Bacterial Agents; Catheter-Related Infections; Community-Acquired Infections; Critical Care; Critical Illness; Cross Infection; Disease Susceptibility; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Postoperative Complications; Prospective Studies; Staphylococcal Infections; Thrombocytopenia; Treatment Outcome | 2009 |
Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Teicoplanin | 2009 |
[Two cases of pulmonary gangrene in HIV-infected patients: favorable outcome without surgery].
Topics: Acetamides; Adult; Alcoholism; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gangrene; Gentamicins; HIV Infections; Humans; Imipenem; Linezolid; Lung; Male; Metronidazole; Necrosis; Ofloxacin; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Smoking; Tomography, X-Ray Computed | 2011 |
Linezolid and clindamycin improve the outcome of severe, necrotizing pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
Topics: Acetamides; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Clindamycin; Combined Modality Therapy; Community-Acquired Infections; Drug Therapy, Combination; Echinocandins; Female; Hemofiltration; Humans; Hydrocortisone; Linezolid; Lipopeptides; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Necrosis; Oxazolidinones; Oxygen Inhalation Therapy; Pneumonia, Bacterial; Pulmonary Aspergillosis; Respiration, Artificial; Shock, Septic; Staphylococcal Infections | 2011 |
Staphylococcus aureus with decreased susceptibility to glycopeptides in cystic fibrosis patients.
Topics: Acetamides; Adolescent; Adult; Anti-Infective Agents; Child; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Glycopeptides; Humans; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Young Adult | 2011 |
Diagnosis and management of community-acquired pneumonia in adults.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Influenza Vaccines; Linezolid; Macrolides; Oxazolidinones; Pneumococcal Vaccines; Pneumonia, Bacterial; Practice Guidelines as Topic; Risk Factors; Treatment Outcome; United States; Vancomycin | 2011 |
[Microbial spectrum of nosocomial pneumonia in traumatological patients].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Female; Hospitals; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Wounds and Injuries | 2011 |
Pneumonia and bacteremia due to Kytococcus schroeteri.
Topics: Acetamides; Actinomycetales; Actinomycetales Infections; Adult; Anti-Bacterial Agents; Bacteremia; Female; Humans; Immunocompromised Host; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Linezolid is superior to vancomycin in experimental pneumonia caused by Superantigen-Producing staphylococcus aureus in HLA class II transgenic mice.
Topics: Acetamides; Animals; Linezolid; Mice; Mice, Inbred BALB C; Mice, Transgenic; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Vancomycin | 2012 |
Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Comorbidity; Empirical Research; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prevalence; Proportional Hazards Models; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
Linezolid: new preparation. In severe gram-positive infections.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Evaluation; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome | 2003 |
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Logistic Models; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Survival Analysis; Survival Rate; Vancomycin | 2004 |
Linezolid better than vancomycin in treating drug-resistant pneumonia.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2004 |
Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia.
Topics: Acetamides; Cross Infection; Female; Follow-Up Studies; Humans; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Risk Assessment; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2004 |
Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain.
Topics: Acetamides; Cost Savings; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Health Care Costs; Humans; Linezolid; Male; National Health Programs; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Respiration, Artificial; Retrospective Studies; Spain; Survival Analysis; Treatment Outcome; Vancomycin | 2005 |
Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Cross Infection; Female; Hospitals, University; Humans; Intensive Care Units; Linezolid; Lung; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial; Respiratory Mucosa | 2005 |
An excellent pharmacokinetic profile can actually act as a double-edged sword.
Topics: Acetamides; Critical Care; Critical Illness; Humans; Intensive Care Units; Intestinal Mucosa; Linezolid; Lung; Oxazolidinones; Pneumonia, Bacterial; Prognosis; Respiration, Artificial; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome | 2006 |
Effectiveness of linezolid and imipenem association in the treatment of severe community-acquired pneumonia in children: two case reports.
Topics: Acetamides; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Safety; Treatment Outcome | 2006 |